Precision Neuroscience, Medtronic Team Up on BCI Tech

Precision Neuroscience began a strategic partnership to advance neurosurgery, using Precision’s brain-computer interface (BCI) technology and Medtronic’s Neuroscience portfolio.

The companies will co-develop a technology that merges Precision’s Layer 7 cortical interface with the Medtronic StealthStation surgical navigation system.

Neurosurgeons often relay on different tools to visualize brain structure and function, which may limit the speed of intra-operative decision-making. This collaboration combines Precision’s high-resolution electrode tech and Medtronic’s real-time 3D surgical navigation platform to offer an end-to-end system designed for real-time functional and structural information in the operating room.

“Our work with Medtronic represents an important step toward advancing how the field understands and interacts with the human brain,” said Michael Mager, CEO of Precision Neuroscience. “Precision’s minimally invasive approach allows this technology to reach widespread clinical use, opening the door to new insights and breakthroughs. Partnering with Medtronic accelerates that path— Medtronic’s Cranial & Spinal Technologies business provides ubiquitous and trusted platforms in neurosurgery, and integrating our technology into a tool surgeons already rely on represents a step change in how quickly we can bring these capabilities into everyday practice.”

“At Medtronic, we believe the brain is the next frontier in medicine. For more than 30 years, our products and therapies have improved the lives of patients with neurological conditions. Today, we’re learning more about the brain than ever before,” added Brett Wall, executive VP and president of Medtronic’s Neuroscience Portfolio. “By integrating Precision Neuroscience’s advanced brain mapping technology with our trusted cranial and spinal technology, we’re exploring the future of cranial surgery and accelerating the global adoption of adaptive, intelligent therapies. These kinds of partnerships are not about chasing trends—it’s about delivering real, meaningful breakthroughs for patients and setting new standards for neurological care worldwide.”